Janus Henderson Group’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-304,556
Closed -$5.67M 2550
2023
Q3
$5.67M Sell
304,556
-68,387
-18% -$1.42M ﹤0.01% 787
2023
Q2
$9.69M Sell
372,943
-309,181
-45% -$8.27M 0.01% 697
2023
Q1
$19.6M Buy
682,124
+68,418
+11% +$2.04M 0.01% 584
2022
Q4
$18.2M Sell
613,706
-616,688
-50% -$17.5M 0.01% 589
2022
Q3
$29.3M Buy
1,230,394
+545,633
+80% +$12.6M 0.01% 609
2022
Q2
$15.3M Sell
684,761
-5
-0% -$112 0.01% 612
2022
Q1
$17.2M Buy
684,766
+112,871
+20% +$3.44M 0.01% 781
2021
Q4
$20.5M Buy
571,895
+108,110
+23% +$4.33M 0.01% 781
2021
Q3
$19.7M Buy
463,785
+259,147
+127% +$10.7M 0.01% 800
2021
Q2
$8.86M Buy
+204,638
New +$8.72M ﹤0.01% 949
2019
Q1
Sell
-7,858
Closed -$264K 1345
2018
Q4
$264K Buy
7,858
+168
+2% +$6.06K ﹤0.01% 1286
2018
Q3
$324K Buy
+7,690
New +$304K ﹤0.01% 1372

Other funds holding ANIK